Innovestor

We are proud to be a supporting investor of New Nordics Healthtech Matchmaking, a Slush side event bringing together the brightest minds in healthtech, life sciences, and investing.✨ Finding the right connections at Slush can be overwhelming - this event makes it effortless. Whether you’re a startup raising funding or an investor seeking your next breakthrough, this is your chance to meet the right people from across the Nordic health innovation ecosystem. 📍 Expect an evening of meaningful networking, great discussions, and a relaxed atmosphere with food and drinks flowing. 💚 Register here: https://lnkd.in/eerGrBNk 🗓️ Date: November 19, 18-22 📍 Location: Terkko Health Hub The event is co-organized by: Terkko Health Hub, Health Incubator Helsinki, HealthHub Finland EDIH, Tampere Health, Kuopio Health, Oyster Incubator, Health Tech Hub Copenhagen, Health Founders, and Health Innovation Aarhus Supported by: Tesi, Almaral, Nordic Science Investments, LUMO Labs, and Angelini Ventures.

Meet Paavo!👋 We’re happy to welcome Paavo Grönqvist, who has joined our Real Estate team as a Trainee! Who is Paavo? Paavo is a third-year Real Estate Economics student at Aalto University with a curious, proactive, and diligent attitude. Prior to joining Innovestor, he gained experience in residential real estate management, with a focus on IT and analytical responsibilities. Outside of work, Paavo enjoys learning new things and challenging himself – both professionally and on the golf course.⛳️ What made him choose Innovestor? Paavo was drawn to Innovestor by its strong team spirit and collaborative culture. He was also inspired by the opportunity to work alongside talented people who share a forward-looking mindset. Moreover, being part of a small and dynamic team gives him a unique opportunity to gain broad exposure to the real estate field early in his career. What is he looking forward to in the coming year? In the upcoming year, Paavo is looking forward to deepening his expertise and growing professionally by contributing to a wide variety of projects. He is eager to learn from experienced colleagues, take on new challenges, and work closely with his team to make a positive impact. Welcome aboard, Paavo! Great to have you on the team!🙌

Partnering in full swing at Sachs Biotech in Europe Forum. Find, partner, repeat!

It was a pleasure to host the first-ever Pitch Finland event dedicated to the creative industries together with Finnish Business Angels Network (FiBAN) here at our office. The event gathered founders and investors from fashion, design, games, and arts to share ideas and highlight the potential of Finland’s creative startup scene. A huge thanks to everyone who joined us yesterday. Great conversations and plenty of inspiration!💫

Founders! Stretch your muscles (and your network) before Slush🔥 On Slush Day 0, we’re bringing together 25 ambitious early-stage tech founders for a morning of bouldering, lunch, and networking. Climb & Connect with Innovestor is your chance to meet peers, swap ideas, and start the week off the ground before the madness begins. If you’re an early-stage founder building in Finland -  or exploring opportunities to operate here - we’d love to meet you! 📅 Tuesday, November 18 | 09:00–11:30 📍 Helsinki (location shared with confirmed guests) Only 25 spots available, so apply fast to secure your spot! More info & registration: https://lnkd.in/dWAzQr7v

A Finnish sofa-in-a-box taking over Europe! 🛋️ Kauppalehti just featured KOTA company, one of our Angel CoFund portfolio companies, and their impressive growth story. The company was founded by former KONE executives Visa Fristrom and Jukka Salmikuukka together with designer Andras Kelemen. Kota set out to create a better sofa that is easy to ship, simple to assemble and comfortable to sleep on. Since launch, Kota has grown at an exceptional pace. Monthly sales have increased by an average of 35% every month since June 2024. In August 2025, sales reached around €700,000, up from only €10,000 in June 2024. The products are now sold in more than 30 markets, with 70% of revenue coming from exports. Read more in Kauppalehti: https://lnkd.in/ds4Qwhhd Innovestor couldn’t be more proud to support the Kota team on their journey to build a new generation of Nordic consumer brands!💪

Sharing knowledge is one of the most effective ways to support founders. Yesterday, we hosted our regular PALO Alumni meetup for our portfolio companies, this time with a focus on funding and in particular the shifting public funding environment. With major changes coming to Business Finland’s instruments, we wanted to help our early-stage founders navigate what’s next. For that, we invited Tommi Pajala, who delivered clear, actionable insights on the evolving landscape. A big thank you to everyone who joined the discussion, and especially to Tommi for bringing clarity to an important (and timely!) topic. 🙌

What is the outlook for investments in the Nordic life science industry in 2025? Amidst global unrest on both the financial and political stages, we sat down with three life science investors to get their take on what’s trending this year. Here are some of the highlights they shared: 𝗪𝗵𝗮𝘁 𝗱𝗼 𝘆𝗼𝘂 𝗽𝗿𝗲𝗱𝗶𝗰𝘁 𝘄𝗶𝗹𝗹 𝗯𝗲 𝘁𝗵𝗲 𝗱𝗼𝗺𝗶𝗻𝗮𝗻𝘁 𝗺𝗮𝗿𝗸𝗲𝘁 𝘁𝗿𝗲𝗻𝗱 𝘄𝗶𝘁𝗵𝗶𝗻 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲𝘀 𝘁𝗵𝗶𝘀 𝘆𝗲𝗮𝗿? “From a content perspective, we continue to see many interesting innovations related to the increase in healthcare data, such as quantum computing and sensing as well as other AI-driven improvements to drive clinical implementation. Additionally, we see growing interest in technologies that support value-based care – solutions that not only improve patient results but also drive cost-efficiency, which is increasingly critical as healthcare systems face mounting pressure on resources,” says Susanna Francke Rodau, CEO & Managing Partner, Segulah Medical Acceleration. 𝗪𝗵𝗮𝘁 𝗮𝗱𝘃𝗶𝗰𝗲 𝗱𝗼 𝘆𝗼𝘂 𝗵𝗮𝘃𝗲 𝗳𝗼𝗿 𝘀𝗺𝗮𝗹𝗹 𝗮𝗻𝗱 𝗺𝗶𝗱-𝘀𝗶𝘇𝗲𝗱 𝗡𝗼𝗿𝗱𝗶𝗰 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝘁𝗼 𝗿𝗮𝗶𝘀𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹? “In the current market environment fundraising still takes time. Start talking to investors well before you need more capital. Building a syndicate, aligning everyone’s interests and closing the investment can take more than 12 months even for the most investable companies. During the process, keep in mind that investors communicate with each other. Ensure your messaging remains consistent and be realistic with expected funding terms,” says Milla Koistinaho, Founding Partner at Innovestor Life Science. 𝗪𝗵𝗮𝘁 𝗱𝗼 𝘆𝗼𝘂 𝗲𝘅𝗽𝗲𝗰𝘁 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗹𝗶𝗳𝗲 𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗹𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 𝘁𝗵𝗶𝘀 𝘆𝗲𝗮𝗿? “I think in 2025 continued valuation contraction and ongoing funding scarcity are going to push many companies to consider acquisition as a viable path forward. International players, particularly from Asia and the US are going to show more strategic interest in entering the European market through targeted acquisitions, drawn by the region’s strong innovation base,” says Farzad Abdi-Dezfuli, Partner at Sarsia Management. Get the full insights shared by these experts in our three Investment Outlook articles: • Milla Koistinaho, Innovestor Life Science https://lnkd.in/djbNtMqJ • Susanna Francke Rodau, Segulah Medical Acceleration (SMA) https://lnkd.in/d-ugbheV • Farzad Abdi-Dezfuli, Sarsia Management https://lnkd.in/dVZcV7wg --- 𝗧𝗵𝗲𝘀𝗲 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁-𝗳𝗼𝗰𝘂𝘀𝗲𝗱 𝗮𝗿𝘁𝗶𝗰𝗹𝗲𝘀 𝗮𝗿𝗲 𝘂𝗻𝗹𝗼𝗰𝗸𝗲𝗱 𝗮𝗻𝗱 𝗳𝗿𝗲𝗲 𝗳𝗼𝗿 𝗮𝗹𝗹 𝘁𝗼 𝗿𝗲𝗮𝗱. To access Nordic Life Science's complete selection of articles and insights, subscribe here: https://lnkd.in/epwjUPJa

We're proud to support our portfolio company Neumirna Therapeutics as they welcome Ellen Wittmack Donnelly as their new CEO!👏 With deep experience in neuroscience drug development, Ellen will be steering the company into its next chapter of clinical entry with NMT-001 and supporting growth and innovation. A big congratulations to Ellen and the entire Neumirna team!